Arcus Biosciences Inc.(RCUS)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RCUS Arcus Biosciences Inc.

休市中 07-26 16:00:00 EDT

15.81

+0.83

+5.54%

盘后15.81

+0.000.00%

16:10 EDT

最高15.91	最低15.08	成交量43.39万
今开15.33	昨收14.98	日振幅5.54%
总市值14.38亿	流通市值8.05亿	总股本9,095万
成交额679.70万	换手率0.85%	流通股本5,094万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RCUS","market":"US","secType":"STK","nameCN":"Arcus Biosciences Inc.","latestPrice":15.81,"timestamp":1722024000000,"preClose":14.98,"halted":0,"volume":433942,"hourTrading":{"tag":"盘后","latestPrice":15.81,"preClose":15.81,"latestTime":"16:10 EDT","volume":13654,"amount":215869.74,"timestamp":1722024605398},"delay":0,"floatShares":50938088,"shares":90953011,"eps":-2.98965,"marketStatus":"休市中","marketStatusCode":7,"change":0.83,"latestTime":"07-26 16:00:00 EDT","open":15.33,"high":15.91,"low":15.08,"amount":6796983.689932,"amplitude":0.055407,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.98965,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"listingDate":1521086400000,"adjPreClose":14.98,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":15.81,"preClose":15.81,"latestTime":"16:10 EDT","volume":13654,"amount":215869.74,"timestamp":1722024605398},"volumeRatio":0.9430413806239445,"impliedVol":0.5859,"impliedVolPercentile":0.1627},"requestUrl":"/m/hq/s/RCUS/tweets","defaultTab":"tweets","newsList":[{"id":"2454747213","title":"Arcus Biosciences, Inc.盘中异动 大幅拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454747213","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454747213?lang=zh_cn&edition=full","pubTime":"2024-07-27 03:11","pubTimestamp":1722021079,"startTime":"0","endTime":"0","summary":"北京时间2024年07月27日03时11分，Arcus Biosciences, Inc.股票出现异动，股价快速拉升5.01%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Windtree Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为7494.32%、252.60%、188.70%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Windtree Therapeutics, Inc.、Cel-Sci Corporation，振幅分别为301.19%、98.48%、91.73%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727031120af945e21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727031120af945e21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2452456295","title":"Arcus Biosciences, Inc.盘中异动 快速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452456295","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452456295?lang=zh_cn&edition=full","pubTime":"2024-07-19 03:22","pubTimestamp":1721330561,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日03时22分，Arcus Biosciences, Inc.股票出现波动，股价急速跳水5.10%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.28%。其相关个股中，Silo Pharma, Inc.、Onconetix, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为3364.65%、2765.51%、1319.21%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719032241aefa5be6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719032241aefa5be6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2450936800","title":"Arcus Biosciences, Inc.盘中异动 早盘股价大涨5.02%报14.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450936800","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450936800?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:36","pubTimestamp":1720705013,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时36分，Arcus Biosciences, Inc.股票出现波动，股价急速拉升5.02%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。消息层面，截至21时36分，《巴克莱银行维持Arcus Biosciences买入评级，维持目标价25美元》资讯为影响Arcus Biosciences, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213654aef93d1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213654aef93d1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2450385481","title":"美国研究综述-Nvidia、高通、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2450385481","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450385481?lang=zh_cn&edition=full","pubTime":"2024-07-10 15:41","pubTimestamp":1720597288,"startTime":"0","endTime":"0","summary":"    路透7月10日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括Nvidia、高通和特斯拉。* Nvidia Corp   ：KeyBanc将目标价上调至180美元 * 高通公司   ：KeyBanc将目标价上调至225美元  * 特斯拉  ：汇丰银行将目标价从120美元上调至130美元  以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","QCOM","JXN","BHF","LU1169590202.USD","NBIX","LGIH","MPWR","NICE","RCUS","FIVN","SG9999014575.USD","PRU","PRI","CRUS","ENLC","BK4559","MOH","DVN","BAH","GL","IE0004445015.USD","MU","KO","LU2237443382.USD","SAIC","TWLO","TSLA","AFL","NVDA","BK4177","RGA","LZ","RNG","AMP","ON","TSLL","DNLI","AMD","MRVL","CACI","CNC","CNO","LDOS","SG9999015986.USD","PFG","EQH","LU2237443549.SGD","SAGE","KDP"],"gpt_icon":1},{"id":"2449763260","title":"Arcus Biosciences, Inc.盘中异动 大幅下挫5.22%报13.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449763260","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449763260?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:37","pubTimestamp":1720186638,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时37分，Arcus Biosciences, Inc.股票出现异动，股价快速跳水5.22%。截至发稿，该股报13.61美元/股，成交量4.782万股，换手率0.05%，振幅1.11%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Qualigen Therapeutics, Inc.、Mediwound Ltd.涨幅较大，Qualigen Therapeutics, Inc.、Kintara Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为905.55%、546.68%、26.81%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为147.47%、29.69%、27.43%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213718aef82d14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213718aef82d14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2449261393","title":"BUZZ-罗氏肺癌药物试验失败，抗 TIGIT 药物生产商业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2449261393","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449261393?lang=zh_cn&edition=full","pubTime":"2024-07-05 20:17","pubTimestamp":1720181839,"startTime":"0","endTime":"0","summary":" (更新)    7月5日 - ** 在美国上市的以色列疗法开发商Compugen  股价盘前下跌3%至1.62美元。** 总部位于瑞士的罗氏公司  的药物tiragolumab周四未能通过肺癌治疗试验。** CGEN正在开发治疗 结直肠癌、卵巢癌和肺癌的药物，这些药物通过作用于TIGIT受体发挥作用，TIGIT受体抑制免疫系统细胞的增殖和激活** 其他抗 TIGIT 药物生产商 Iteos Therapeutics   下跌 8.6%，Arcus Biosciences   下跌 3.5** 截至上次收盘，CGEN下跌 15.6%，RCUS下跌24.8%，ITOS今年上涨35","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGEN","BUZZ","RCUS","BK4121","BK4139","ITOS"],"gpt_icon":0},{"id":"2448098169","title":"Arcus Biosciences, Inc.盘中异动 快速跳水5.03%报14.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448098169","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448098169?lang=zh_cn&edition=full","pubTime":"2024-07-03 00:03","pubTimestamp":1719936181,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日00时03分，Arcus Biosciences, Inc.股票出现异动，股价大幅下跌5.03%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。其相关个股中，Annovis Bio, Inc.、Zura Bio Limited C/Wts 、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Mustang Bio, Inc.、Gri Bio, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为55.44%、49.54%、39.44%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Annovis Bio, Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为72.83%、43.07%、39.76%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703000301af903722&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703000301af903722&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2446825846","title":"Arcus Biosciences, Inc.盘中异动 临近午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446825846","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446825846?lang=zh_cn&edition=full","pubTime":"2024-06-25 23:36","pubTimestamp":1719329766,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日23时36分，Arcus Biosciences, Inc.股票出现波动，股价快速下跌5.12%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.98%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625233607aef68a30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625233607aef68a30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2445780640","title":"美国研究综述-CarMax、礼来公司、微策略公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2445780640","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445780640?lang=zh_cn&edition=full","pubTime":"2024-06-24 19:57","pubTimestamp":1719230267,"startTime":"0","endTime":"0","summary":"    路透6月24日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 CarMax、礼来和 MicroStrategy。股票条目按字母顺序排列。* Agilysys Inc   ：威廉-布莱尔给予该公司 \"跑赢大盘 \"的评级。* Ally Financial Inc   ：花旗集团给予该公司买入评级，目标价50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIO","AAPL","AEE","LNG","ESS","LU1712237335.SGD","CNK","LU1623119135.USD","EA","BK4532","EWBC","KMX","LLY","BK4082","FITB","NVDA","CFR","DAY","ASB","EQR","CPT","DLR","T","CYTK","MSTR","BKU","CPAY","BK4108","CADE","NVRI","LU0011850046.USD","CARR","DMRC","BK4227","CMA","COCH","ARGX","FDX","FHN","LU0097036916.USD","GTLS","ALLY","LU0820561909.HKD","FHB","COLB","AVB","FDS","IE0009355771.USD","RCUS","CYRX","BOKF","AGYS"],"gpt_icon":0},{"id":"2444711317","title":"Arcus Biosciences, Inc.盘中异动 快速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444711317","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444711317?lang=zh_cn&edition=full","pubTime":"2024-06-18 02:35","pubTimestamp":1718649333,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日02时35分，Arcus Biosciences, Inc.股票出现异动，股价急速跳水5.01%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Biocardia Inc C/Wts 06/08/2024涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为5014.03%、3115.71%、181.11%，振幅较大的相关个股有Mustang Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Scinai Immunotherapeutics Ltd，振幅分别为313.08%、79.35%、53.30%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618023534aef54cd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618023534aef54cd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2443634895","title":"Arcus Biosciences, Inc.盘中异动 快速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443634895","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443634895?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:52","pubTimestamp":1718301158,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时52分，Arcus Biosciences, Inc.股票出现异动，股价急速上涨5.19%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。消息层面，截至01时52分，《BTIG维持Arcus Biosciences买入评级，维持目标价70美元》资讯为影响Arcus Biosciences, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614015239aef4d867&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614015239aef4d867&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139","LGVN"],"gpt_icon":0},{"id":"2442941554","title":"Arcus Biosciences, Inc.盘中异动 快速拉升5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442941554","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442941554?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:32","pubTimestamp":1718199160,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时32分，Arcus Biosciences, Inc.股票出现波动，股价快速拉升5.37%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。消息层面，截至21时32分，《BTIG维持Arcus Biosciences买入评级，维持目标价70美元》资讯为影响Arcus Biosciences, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213240af8d2fa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213240af8d2fa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2440496856","title":"Arcus Biosciences, Inc.盘中异动 早盘股价大涨5.28%报15.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440496856","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440496856?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:32","pubTimestamp":1717421557,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时32分，Arcus Biosciences, Inc.股票出现异动，股价大幅上涨5.28%。截至发稿，该股报15.87美元/股，成交量8.5618万股，换手率0.09%，振幅1.13%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406032132379f156c24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406032132379f156c24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2439586877","title":"健康巡回：试验性疗法可延缓晚期结肠癌的发展，提高生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=2439586877","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439586877?lang=zh_cn&edition=full","pubTime":"2024-05-29 02:04","pubTimestamp":1716919480,"startTime":"0","endTime":"0","summary":"今天，我们将在本周末举行的本年度最重要的肿瘤学会议上重点介绍另一项研究，该研究是一种联合疗法，可延缓晚期结肠癌的进展并提高其生存率。Arcus疗法可延缓晚期结直肠癌的发展一项中期试验的数据显示，Arcus生物科学公司  正在开发一种新的治疗方法，其中包括一对实验性免疫疗法药物，它对那些尽管接受了标准治疗但晚期结直肠癌仍继续扩散的患者显示出了良好的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4195","RCUS","PFS","BK4211"],"gpt_icon":0},{"id":"2439586871","title":"健康巡回：试验性疗法可延缓晚期结肠癌的发展，提高生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=2439586871","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439586871?lang=zh_cn&edition=full","pubTime":"2024-05-29 02:04","pubTimestamp":1716919480,"startTime":"0","endTime":"0","summary":"今天，我们将在本周末举行的本年度最重要的肿瘤学会议上重点介绍另一项研究，该研究是一种联合疗法，可延缓晚期结肠癌的进展并提高其生存率。Arcus疗法可延缓晚期结直肠癌的发展一项中期试验的数据显示，Arcus生物科学公司  正在开发一种新的治疗方法，其中包括一对实验性免疫疗法药物，它对那些尽管接受了标准治疗但晚期结直肠癌仍继续扩散的患者显示出了良好的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4195","PFS","BK4211","RCUS","BK4139"],"gpt_icon":0},{"id":"2437030835","title":"Arcus Biosciences, Inc.盘中异动 快速上涨5.28%报17.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437030835","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437030835?lang=zh_cn&edition=full","pubTime":"2024-05-24 21:32","pubTimestamp":1716557533,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日21时32分，Arcus Biosciences, Inc.股票出现波动，股价急速上涨5.28%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。消息层面，截至21时32分，《美银证券维持Arcus Biosciences持有评级，维持目标价24美元》资讯为影响Arcus Biosciences, Inc.的重要信息。根据TipRanks数据显示，该分析师近一年总胜率为53.8%，总平均回报率为16.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242132149559417b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242132149559417b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2437736703","title":"Arcus Biosciences Inc：花旗集团将目标价格从37美元下调至36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437736703","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437736703?lang=zh_cn&edition=full","pubTime":"2024-05-23 18:06","pubTimestamp":1716458803,"startTime":"0","endTime":"0","summary":"Arcus Biosciences Inc：花旗集团将目标价格从37美元下调至36美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405231806449edc9e29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405231806449edc9e29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS"],"gpt_icon":0},{"id":"2436456479","title":"Arcus Biosciences, Inc.2024财年第一财季实现净利润-4.00百万美元，同比增加95.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436456479","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436456479?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:16","pubTimestamp":1715962593,"startTime":"0","endTime":"0","summary":"3月31日，Arcus Biosciences, Inc.公布财报，公告显示公司2024财年第一财季净利润为-4.00百万美元，同比增加95.00%；其中营业收入为1.45亿美元，同比增加480.00%，每股基本收益为-0.05美元。机构评级：截至2024年3月31日，当前有10家机构对Arcus Biosciences, Inc.目标价做出预测，其中目标均价为38.70美元，其中最低目标价为24.00美元，最高目标价为70.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180016378b13177b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180016378b13177b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS"],"gpt_icon":0},{"id":"2434018206","title":"Arcus Biosciences, Inc.盘中异动 早盘大幅上涨6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434018206","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434018206?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:35","pubTimestamp":1715261705,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时35分，Arcus Biosciences, Inc.股票出现波动，股价急速拉升6.23%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。消息层面，截至21时35分，《Wedbush：重申Arcus Biosciences评级，由优于大市调整至优于大市评级, 目标价30.00美元。》资讯为影响Arcus Biosciences, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921350687e5103b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921350687e5103b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2434097413","title":"Wedbush：重申Arcus Biosciences(RCUS.US)评级，由优于大市调整至优于大市评级, 目标价30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434097413","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434097413?lang=zh_cn&edition=full","pubTime":"2024-05-09 20:56","pubTimestamp":1715259370,"startTime":"0","endTime":"0","summary":"Wedbush：重申Arcus Biosciences(RCUS.US)评级，由优于大市调整至优于大市评级, 目标价30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092056228aecf4d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092056228aecf4d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcusbio.com","stockEarnings":[{"period":"1week","weight":0.1071},{"period":"1month","weight":0.0429},{"period":"3month","weight":0.0167},{"period":"6month","weight":0.0449},{"period":"1year","weight":-0.1892},{"period":"ytd","weight":-0.1723}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0712},{"period":"6month","weight":0.117},{"period":"1year","weight":0.2032},{"period":"ytd","weight":0.1454}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcus Biosciences, Inc.于2015年4月30日在特拉华州成立。它们是一家临床阶段的生物制药公司，致力于通过利用开发不足的生物机会创造创新的癌症免疫疗法。具体而言，他们针对特征明确的生物学途径，并提供重要的科学数据支持其调节对癌症的免疫反应的重要性，并且无论是在开发中的分子还是在存在具有次优分布的分子。为了利用这些途径，他们建立了强大而高效的发现能力，以创建和优化高度分化的小分子免疫肿瘤产品候选物。自2015年成立以来，他们已经建立了广泛的小分子和抗体产品候选组合，他们计划共同开发内部组合产品。他们已经启动了两项最先进的候选产品的临床试验，这两种产品预计将在2018年产生数据，并且他们预计在2019年上半年将从他们的第一批产品组合中获得临床数据。他们计划推出两种附加产品候选人到2018年底进入临床试验阶段。Arcus团队的成员共同工作了10多年，在Tularik Inc.，Amgen，Inc.和Flexus Biosciences，Inc.等公司中发现创新的小分子产品候选人。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.041485},{"month":2,"riseRate":0.833333,"avgChangeRate":0.203543},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.065889},{"month":4,"riseRate":0.285714,"avgChangeRate":0.060148},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.033648},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.008856},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.006086},{"month":8,"riseRate":0.5,"avgChangeRate":0.048653},{"month":9,"riseRate":0.5,"avgChangeRate":0.001799},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.056055},{"month":11,"riseRate":0.833333,"avgChangeRate":0.181273},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.017007}],"exchange":"NYSE","name":"Arcus Biosciences Inc.","nameEN":"Arcus Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcus Biosciences Inc.(RCUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arcus Biosciences Inc.(RCUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arcus Biosciences Inc.,RCUS,Arcus Biosciences Inc.股票,Arcus Biosciences Inc.股票老虎,Arcus Biosciences Inc.股票老虎国际,Arcus Biosciences Inc.行情,Arcus Biosciences Inc.股票行情,Arcus Biosciences Inc.股价,Arcus Biosciences Inc.股市,Arcus Biosciences Inc.股票价格,Arcus Biosciences Inc.股票交易,Arcus Biosciences Inc.股票购买,Arcus Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcus Biosciences Inc.(RCUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arcus Biosciences Inc.(RCUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况